Unicycive Therapeutics, Inc.

Healthcare

NASDAQ:UNCY · NASDAQ Capital Market

Market Cap $155.81M Beta 1.73 P/E (TTM) -43.4

$7.17 -5.72%

-$0.44 today

52W Low $3.71High $8.74

Vol 1.11M · Avg 0.63M

EPS (TTM) -$0.17Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+4.37%

Period High

$8.56

Period Low

$3.74

Latest

$7.17

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$487.67M

Immunic, Inc.

NASDAQ:IMUX

$136.78M

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Repare Therapeutics Inc.

RPTX

$114.24M

CAMP4 Therapeutics Corporation

NASDAQ:CAMP

$89.00M

MindWalk Holdings Corp.

NASDAQ:HYFT

$72.87M

Biomea Fusion, Inc.

NASDAQ:BMEA

$69.61M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$59.20M

Cibus, Inc.

NASDAQ:CBUS

$55.95M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$46.70M

What is the latest UNCY filing?

The latest filing shown is S-3 dated Jun 5, 2026.

How many recent filings does UNCY have?

Intrinsic Alpha currently shows 20 recent filings for UNCY.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.